A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1

A persistent problem in early small-molecule drug discovery is the frequent lack of rank-order correlation between biochemical potencies derived from initial screens using purified proteins and the diminished potency and efficacy observed in subsequent disease-relevant cellular phenotypic assays. Th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:SLAS discovery 2018-01, Vol.23 (1), p.34-46
Hauptverfasser: McNulty, Dean E., Bonnette, William G., Qi, Hongwei, Wang, Liping, Ho, Thau F., Waszkiewicz, Anna, Kallal, Lorena A., Nagarajan, Raman P., Stern, Melissa, Quinn, Amy M., Creasy, Caretha L., Su, Dai-Shi, Graves, Alan P., Annan, Roland S., Sweitzer, Sharon M., Holbert, Marc A.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 46
container_issue 1
container_start_page 34
container_title SLAS discovery
container_volume 23
creator McNulty, Dean E.
Bonnette, William G.
Qi, Hongwei
Wang, Liping
Ho, Thau F.
Waszkiewicz, Anna
Kallal, Lorena A.
Nagarajan, Raman P.
Stern, Melissa
Quinn, Amy M.
Creasy, Caretha L.
Su, Dai-Shi
Graves, Alan P.
Annan, Roland S.
Sweitzer, Sharon M.
Holbert, Marc A.
description A persistent problem in early small-molecule drug discovery is the frequent lack of rank-order correlation between biochemical potencies derived from initial screens using purified proteins and the diminished potency and efficacy observed in subsequent disease-relevant cellular phenotypic assays. The introduction of the cellular thermal shift assay (CETSA) has bridged this gap by enabling assessment of drug target engagement directly in live cells based on ligand-induced changes in protein thermal stability. Initial success in applying CETSA across multiple drug target classes motivated our investigation into replacing the low-throughput, manually intensive Western blot readout with a quantitative, automated higher-throughput assay that would provide sufficient capacity to use CETSA as a primary hit qualification strategy. We introduce a high-throughput dose-response cellular thermal shift assay (HTDR-CETSA), a single-pot homogenous assay adapted for high-density microtiter plate format. The assay features titratable BacMam expression of full-length target proteins fused to the DiscoverX 42 amino acid ePL tag in HeLa suspension cells, facilitating enzyme fragment complementation–based chemiluminescent quantification of ligand-stabilized soluble protein. This simplified format can accommodate determination of full-dose CETSA curves for hundreds of individual compounds/analyst/day in replicates. HTDR-CETSA data generated for substrate site and alternate binding mode inhibitors of the histone-lysine N-methyltransferase SMYD3 in HeLa suspension cells demonstrate excellent correlation with rank-order potencies observed in cellular mechanistic assays and direct translation to target engagement of endogenous Smyd3 in cancer-relevant cell lines. We envision this workflow to be generically applicable to HTDR-CETSA screening spanning a wide variety of soluble intracellular protein target classes.
doi_str_mv 10.1177/2472555217732014
format Article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1177_2472555217732014</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2472555217732014</sage_id><sourcerecordid>10.1177_2472555217732014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-fd0ae5493393684fd1fa0974291346fc2ce500f2e46d9b2721ff7b736aa778743</originalsourceid><addsrcrecordid>eNp1UE1r20AUXEpLHJLccyrvB1TJfmqto7HdOOASiJ1DT2ItvZU26ItdqdT_pT82Ek58KIR3eMN7MwMzhNwyeseY1vdcaq6U4iMWnDL5hVxOp0ipmH49Y8Vn5CaEV0op07EY54LM-DxROpbxJfm3gI0rymhf-nYoym7oYdUGjJ4xdG0TEJZYVUNlPOxL9LWpYFc628MiBHME23p4Np3LYZd5xMY1BbQWVn4oYG98gT2sm8IUWGPTg2tg6_5MnMk0_ID1X6y7ylmHObyE6bH79XslwDQ5PK6e2DX5Zk0V8OZ9X5GXn-v9chNtnx4el4ttlAmd9JHNqUElEyESEc-lzZk1NNGSJ0zI2GY8Q0Wp5SjjPDlwzZm1-qBFbIzWcy3FFaEn38y3IXi0aeddbfwxZTSduk7_73qUfD9JuuFQY34WfDQ7EqITIYzx09d28M0Y4XPDN4Xoha0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>McNulty, Dean E. ; Bonnette, William G. ; Qi, Hongwei ; Wang, Liping ; Ho, Thau F. ; Waszkiewicz, Anna ; Kallal, Lorena A. ; Nagarajan, Raman P. ; Stern, Melissa ; Quinn, Amy M. ; Creasy, Caretha L. ; Su, Dai-Shi ; Graves, Alan P. ; Annan, Roland S. ; Sweitzer, Sharon M. ; Holbert, Marc A.</creator><creatorcontrib>McNulty, Dean E. ; Bonnette, William G. ; Qi, Hongwei ; Wang, Liping ; Ho, Thau F. ; Waszkiewicz, Anna ; Kallal, Lorena A. ; Nagarajan, Raman P. ; Stern, Melissa ; Quinn, Amy M. ; Creasy, Caretha L. ; Su, Dai-Shi ; Graves, Alan P. ; Annan, Roland S. ; Sweitzer, Sharon M. ; Holbert, Marc A.</creatorcontrib><description>A persistent problem in early small-molecule drug discovery is the frequent lack of rank-order correlation between biochemical potencies derived from initial screens using purified proteins and the diminished potency and efficacy observed in subsequent disease-relevant cellular phenotypic assays. The introduction of the cellular thermal shift assay (CETSA) has bridged this gap by enabling assessment of drug target engagement directly in live cells based on ligand-induced changes in protein thermal stability. Initial success in applying CETSA across multiple drug target classes motivated our investigation into replacing the low-throughput, manually intensive Western blot readout with a quantitative, automated higher-throughput assay that would provide sufficient capacity to use CETSA as a primary hit qualification strategy. We introduce a high-throughput dose-response cellular thermal shift assay (HTDR-CETSA), a single-pot homogenous assay adapted for high-density microtiter plate format. The assay features titratable BacMam expression of full-length target proteins fused to the DiscoverX 42 amino acid ePL tag in HeLa suspension cells, facilitating enzyme fragment complementation–based chemiluminescent quantification of ligand-stabilized soluble protein. This simplified format can accommodate determination of full-dose CETSA curves for hundreds of individual compounds/analyst/day in replicates. HTDR-CETSA data generated for substrate site and alternate binding mode inhibitors of the histone-lysine N-methyltransferase SMYD3 in HeLa suspension cells demonstrate excellent correlation with rank-order potencies observed in cellular mechanistic assays and direct translation to target engagement of endogenous Smyd3 in cancer-relevant cell lines. We envision this workflow to be generically applicable to HTDR-CETSA screening spanning a wide variety of soluble intracellular protein target classes.</description><identifier>ISSN: 2472-5552</identifier><identifier>EISSN: 2472-5560</identifier><identifier>DOI: 10.1177/2472555217732014</identifier><identifier>PMID: 28957646</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><ispartof>SLAS discovery, 2018-01, Vol.23 (1), p.34-46</ispartof><rights>2017 Society for Laboratory Automation and Screening</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379t-fd0ae5493393684fd1fa0974291346fc2ce500f2e46d9b2721ff7b736aa778743</citedby><cites>FETCH-LOGICAL-c379t-fd0ae5493393684fd1fa0974291346fc2ce500f2e46d9b2721ff7b736aa778743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28957646$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McNulty, Dean E.</creatorcontrib><creatorcontrib>Bonnette, William G.</creatorcontrib><creatorcontrib>Qi, Hongwei</creatorcontrib><creatorcontrib>Wang, Liping</creatorcontrib><creatorcontrib>Ho, Thau F.</creatorcontrib><creatorcontrib>Waszkiewicz, Anna</creatorcontrib><creatorcontrib>Kallal, Lorena A.</creatorcontrib><creatorcontrib>Nagarajan, Raman P.</creatorcontrib><creatorcontrib>Stern, Melissa</creatorcontrib><creatorcontrib>Quinn, Amy M.</creatorcontrib><creatorcontrib>Creasy, Caretha L.</creatorcontrib><creatorcontrib>Su, Dai-Shi</creatorcontrib><creatorcontrib>Graves, Alan P.</creatorcontrib><creatorcontrib>Annan, Roland S.</creatorcontrib><creatorcontrib>Sweitzer, Sharon M.</creatorcontrib><creatorcontrib>Holbert, Marc A.</creatorcontrib><title>A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1</title><title>SLAS discovery</title><addtitle>J Biomol Screen</addtitle><description>A persistent problem in early small-molecule drug discovery is the frequent lack of rank-order correlation between biochemical potencies derived from initial screens using purified proteins and the diminished potency and efficacy observed in subsequent disease-relevant cellular phenotypic assays. The introduction of the cellular thermal shift assay (CETSA) has bridged this gap by enabling assessment of drug target engagement directly in live cells based on ligand-induced changes in protein thermal stability. Initial success in applying CETSA across multiple drug target classes motivated our investigation into replacing the low-throughput, manually intensive Western blot readout with a quantitative, automated higher-throughput assay that would provide sufficient capacity to use CETSA as a primary hit qualification strategy. We introduce a high-throughput dose-response cellular thermal shift assay (HTDR-CETSA), a single-pot homogenous assay adapted for high-density microtiter plate format. The assay features titratable BacMam expression of full-length target proteins fused to the DiscoverX 42 amino acid ePL tag in HeLa suspension cells, facilitating enzyme fragment complementation–based chemiluminescent quantification of ligand-stabilized soluble protein. This simplified format can accommodate determination of full-dose CETSA curves for hundreds of individual compounds/analyst/day in replicates. HTDR-CETSA data generated for substrate site and alternate binding mode inhibitors of the histone-lysine N-methyltransferase SMYD3 in HeLa suspension cells demonstrate excellent correlation with rank-order potencies observed in cellular mechanistic assays and direct translation to target engagement of endogenous Smyd3 in cancer-relevant cell lines. We envision this workflow to be generically applicable to HTDR-CETSA screening spanning a wide variety of soluble intracellular protein target classes.</description><issn>2472-5552</issn><issn>2472-5560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1UE1r20AUXEpLHJLccyrvB1TJfmqto7HdOOASiJ1DT2ItvZU26ItdqdT_pT82Ek58KIR3eMN7MwMzhNwyeseY1vdcaq6U4iMWnDL5hVxOp0ipmH49Y8Vn5CaEV0op07EY54LM-DxROpbxJfm3gI0rymhf-nYoym7oYdUGjJ4xdG0TEJZYVUNlPOxL9LWpYFc628MiBHME23p4Np3LYZd5xMY1BbQWVn4oYG98gT2sm8IUWGPTg2tg6_5MnMk0_ID1X6y7ylmHObyE6bH79XslwDQ5PK6e2DX5Zk0V8OZ9X5GXn-v9chNtnx4el4ttlAmd9JHNqUElEyESEc-lzZk1NNGSJ0zI2GY8Q0Wp5SjjPDlwzZm1-qBFbIzWcy3FFaEn38y3IXi0aeddbfwxZTSduk7_73qUfD9JuuFQY34WfDQ7EqITIYzx09d28M0Y4XPDN4Xoha0</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>McNulty, Dean E.</creator><creator>Bonnette, William G.</creator><creator>Qi, Hongwei</creator><creator>Wang, Liping</creator><creator>Ho, Thau F.</creator><creator>Waszkiewicz, Anna</creator><creator>Kallal, Lorena A.</creator><creator>Nagarajan, Raman P.</creator><creator>Stern, Melissa</creator><creator>Quinn, Amy M.</creator><creator>Creasy, Caretha L.</creator><creator>Su, Dai-Shi</creator><creator>Graves, Alan P.</creator><creator>Annan, Roland S.</creator><creator>Sweitzer, Sharon M.</creator><creator>Holbert, Marc A.</creator><general>SAGE Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201801</creationdate><title>A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1</title><author>McNulty, Dean E. ; Bonnette, William G. ; Qi, Hongwei ; Wang, Liping ; Ho, Thau F. ; Waszkiewicz, Anna ; Kallal, Lorena A. ; Nagarajan, Raman P. ; Stern, Melissa ; Quinn, Amy M. ; Creasy, Caretha L. ; Su, Dai-Shi ; Graves, Alan P. ; Annan, Roland S. ; Sweitzer, Sharon M. ; Holbert, Marc A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-fd0ae5493393684fd1fa0974291346fc2ce500f2e46d9b2721ff7b736aa778743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McNulty, Dean E.</creatorcontrib><creatorcontrib>Bonnette, William G.</creatorcontrib><creatorcontrib>Qi, Hongwei</creatorcontrib><creatorcontrib>Wang, Liping</creatorcontrib><creatorcontrib>Ho, Thau F.</creatorcontrib><creatorcontrib>Waszkiewicz, Anna</creatorcontrib><creatorcontrib>Kallal, Lorena A.</creatorcontrib><creatorcontrib>Nagarajan, Raman P.</creatorcontrib><creatorcontrib>Stern, Melissa</creatorcontrib><creatorcontrib>Quinn, Amy M.</creatorcontrib><creatorcontrib>Creasy, Caretha L.</creatorcontrib><creatorcontrib>Su, Dai-Shi</creatorcontrib><creatorcontrib>Graves, Alan P.</creatorcontrib><creatorcontrib>Annan, Roland S.</creatorcontrib><creatorcontrib>Sweitzer, Sharon M.</creatorcontrib><creatorcontrib>Holbert, Marc A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>SLAS discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McNulty, Dean E.</au><au>Bonnette, William G.</au><au>Qi, Hongwei</au><au>Wang, Liping</au><au>Ho, Thau F.</au><au>Waszkiewicz, Anna</au><au>Kallal, Lorena A.</au><au>Nagarajan, Raman P.</au><au>Stern, Melissa</au><au>Quinn, Amy M.</au><au>Creasy, Caretha L.</au><au>Su, Dai-Shi</au><au>Graves, Alan P.</au><au>Annan, Roland S.</au><au>Sweitzer, Sharon M.</au><au>Holbert, Marc A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1</atitle><jtitle>SLAS discovery</jtitle><addtitle>J Biomol Screen</addtitle><date>2018-01</date><risdate>2018</risdate><volume>23</volume><issue>1</issue><spage>34</spage><epage>46</epage><pages>34-46</pages><issn>2472-5552</issn><eissn>2472-5560</eissn><abstract>A persistent problem in early small-molecule drug discovery is the frequent lack of rank-order correlation between biochemical potencies derived from initial screens using purified proteins and the diminished potency and efficacy observed in subsequent disease-relevant cellular phenotypic assays. The introduction of the cellular thermal shift assay (CETSA) has bridged this gap by enabling assessment of drug target engagement directly in live cells based on ligand-induced changes in protein thermal stability. Initial success in applying CETSA across multiple drug target classes motivated our investigation into replacing the low-throughput, manually intensive Western blot readout with a quantitative, automated higher-throughput assay that would provide sufficient capacity to use CETSA as a primary hit qualification strategy. We introduce a high-throughput dose-response cellular thermal shift assay (HTDR-CETSA), a single-pot homogenous assay adapted for high-density microtiter plate format. The assay features titratable BacMam expression of full-length target proteins fused to the DiscoverX 42 amino acid ePL tag in HeLa suspension cells, facilitating enzyme fragment complementation–based chemiluminescent quantification of ligand-stabilized soluble protein. This simplified format can accommodate determination of full-dose CETSA curves for hundreds of individual compounds/analyst/day in replicates. HTDR-CETSA data generated for substrate site and alternate binding mode inhibitors of the histone-lysine N-methyltransferase SMYD3 in HeLa suspension cells demonstrate excellent correlation with rank-order potencies observed in cellular mechanistic assays and direct translation to target engagement of endogenous Smyd3 in cancer-relevant cell lines. We envision this workflow to be generically applicable to HTDR-CETSA screening spanning a wide variety of soluble intracellular protein target classes.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>28957646</pmid><doi>10.1177/2472555217732014</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2472-5552
ispartof SLAS discovery, 2018-01, Vol.23 (1), p.34-46
issn 2472-5552
2472-5560
language eng
recordid cdi_crossref_primary_10_1177_2472555217732014
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T17%3A01%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20High-Throughput%20Dose-Response%20Cellular%20Thermal%20Shift%20Assay%20for%20Rapid%20Screening%20of%20Drug%20Target%20Engagement%20in%20Living%20Cells,%20Exemplified%20Using%20SMYD3%20and%20IDO1&rft.jtitle=SLAS%20discovery&rft.au=McNulty,%20Dean%20E.&rft.date=2018-01&rft.volume=23&rft.issue=1&rft.spage=34&rft.epage=46&rft.pages=34-46&rft.issn=2472-5552&rft.eissn=2472-5560&rft_id=info:doi/10.1177/2472555217732014&rft_dat=%3Csage_cross%3E10.1177_2472555217732014%3C/sage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/28957646&rft_sage_id=10.1177_2472555217732014&rfr_iscdi=true